Bicycle Therapeutics PLC (NASDAQ:BCYC)

Delayed Data
As of Jan 21
 -0.48 / -1.03%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 11 analysts offering 12-month price forecasts for Bicycle Therapeutics PLC have a median target of 72.00, with a high estimate of 100.00 and a low estimate of 64.00. The median estimate represents a +56.15% increase from the last price of 46.11.

Analyst Recommendations

The current consensus among 11 polled investment analysts is to Buy stock in Bicycle Therapeutics PLC. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 15

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -4.93%
Growthannually -1.13%


Growthquarterly 24.47%
Growthannually 28.89%
Key to the earnings and sales forecast charts.